68th Day Of Lockdown

Maharashtra65168280812197 Tamil Nadu2024611313157 Delhi173877846398 Gujarat1635692321007 Rajasthan83654855184 Madhya Pradesh78914444343 Uttar Pradesh77014651213 West Bengal48131775302 Andhra Pradesh3461228960 Bihar3359120915 Karnataka292299749 Telangana2499141277 Jammu and Kashmir234190828 Punjab2197194942 Odisha17239779 Haryana172194019 Kerala120957510 Assam9361044 Uttarakhand493794 Jharkhand4621914 Chhatisgarh4471021 Chandigarh2891994 Tripura2711720 Himachal Pradesh223634 Goa70420 Manipur6060 Puducherry57230 Nagaland3600 Meghalaya27121 Arunachal Pradesh310 Mizoram110 Sikkim100
Technology Other News 04 Feb 2020 AI-designed OCD drug ...

AI-designed OCD drug set to be tested on humans

ANI
Published Feb 4, 2020, 6:31 am IST
Updated Feb 4, 2020, 6:31 am IST
The drug is intended to treat obsessive-compulsive disorder and the clinical human trials begin in March.
The drug, known as DSP-1181, has been created using algorithms that scanned through compounds and checked against the database of parameters such as patient's genetic factors.
 (Photo: ANI)
 The drug, known as DSP-1181, has been created using algorithms that scanned through compounds and checked against the database of parameters such as patient's genetic factors.
 (Photo: ANI)

Would you trust artificial intelligence (AI) enough to consume a drug made by it? Researchers at Oxford-based biotech company -- Exscientia -- have reportedly used AI tools to create a drug that is now ready to enter clinical human trials.

According to Engadget, the drug, known as DSP-1181, has been created using algorithms that scanned through compounds and checked against the database of parameters such as patient's genetic factors.

 

The drug is intended to treat obsessive-compulsive disorder and the clinical human trials begin in March.

AI has proven its efficiency in the early diagnosis of certain illnesses. It remains to be seen if patients or medical professionals will be comfortable prescribing something made entirely by a machine.

Click on Deccan Chronicle Technology and Science for the latest news and reviews. Follow us on Facebook, Twitter

...




ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT